Get more Mail & Guardian
Subscribe or Login

Fake medicine is real business in Africa

There’s nothing covert about Roxy, a huge market in Abidjan selling counterfeit medicine, the cause of about 100 000 deaths annually in the world’s poorest continent, according to the World Health Organisation (WHO).

Located in the bustling Adjame quarter of Côte d’Ivoire’s main city and commercial hub, the haven for fake medicine has been targeted time and again by authorities and stockpiles burnt.

But it resurfaces every time.

“The police hassle us but they themselves buy these medicines,” said Mariam, one of the many vendors who hawk everything from painkillers and antibiotics to antimalaria and antiretroviral treatments.

“When we are harassed we always come to an arrangement with them to resume our activities,” she said.

Fatima, another hawker, said: “Many people come here with their prescriptions to buy medicine, even the owners of private clinics.”

She said there was a “syndicate” controlling the sector, which held regular meetings to fix prices and control supply levels.

The illicit sector has a turnover of at least 10% of the world’s pharmaceutical business, meaning that it earns tens of billions of dollars a year, the Switzerland-based World Economic Forum estimates, adding that the figure has nearly tripled in five years.

“To sell fake medicines, you need a clientele. The ailing poor are more numerous in Africa than anywhere in the world,” said Marc Gentilini, a specialist in infectious and tropical diseases and a former head of the French Red Cross.

Gentilini said some meningitis vaccines sent a few years ago after an outbreak in arid Niger were fake. The disease kills thousands every year in the arid West African nation.

The WHO estimates that one in 10 medicines in the world is fake but the figure can be as high as seven in 10 in some countries, especially in Africa.

The American Society of Tropical Medicine and Hygiene estimated in 2015 that 122 000 children under the age of five died because of taking poor-quality antimalarials in sub-Saharan Africa, which, along with antibiotics, are the medicines most likely to be out of date or bad copies.

Interpol in August announced the seizure of 420 tonnes of counterfeit medicine in West Africa in a huge operation that involved about 1 000 police, customs and health officials in seven countries: Benin, Burkina Faso, Côte d’Ivoire, Mali, Niger, Nigeria and Togo.

Geoffroy Bessaud, the head of anti-counterfeit co-ordination at French pharmaceutical giant Sanofi, said fake medicines were the biggest illicit business in the world.

“This phenomenon is spreading. It’s financial attractiveness draws criminal organisations of all sizes,” he said.

“An investment of $1 000 can bring returns of up to $500 000, while for the same kind of investment in the heroin trade or in counterfeit money the amount will be around $20 000.”

Ivorian authorities in May burnt 40 tonnes of fake medicines in Adjame, the biggest street market for fake medicines in West Africa, which accounts for 30% of medicine sales in Ivory Coast.

Offenders remained largely unpunished worldwide and were mainly targeted for breaching intellectual property rights instead of being held responsible for the deaths of hundreds of thousands of people, the Paris-based International Institute of Research against Counterfeit Medicine said.

Experts have called for a global fight against the sale of counterfeit medicine.

Sanofi said in 2016 it had helped to dismantle 27 clandestine laboratories, including 22 in China and the rest in Indonesia, Ukraine and Poland.

In countries where medical expenses — from medicine to being admitted to hospital — are not even partly reimbursed by the state, the cheap street price trumps the risk factor for many.

The outstanding exception on the continent in fighting the illicit drug trade is South Africa, which has a strictly enforced licensing system. — AFP

Subscribe to the M&G

Thanks for enjoying the Mail & Guardian, we’re proud of our 36 year history, throughout which we have delivered to readers the most important, unbiased stories in South Africa. Good journalism costs, though, and right from our very first edition we’ve relied on reader subscriptions to protect our independence.

Digital subscribers get access to all of our award-winning journalism, including premium features, as well as exclusive events, newsletters, webinars and the cryptic crossword. Click here to find out how to join them.

Christophe Koffi
Christophe Koffi
Social and environmental scientist, focused on forest, food security and climate change adaptation.

Related stories


If you’re reading this, you clearly have great taste

If you haven’t already, you can subscribe to the Mail & Guardian for less than the cost of a cup of coffee a week, and get more great reads.

Already a subscriber? Sign in here


Subscribers only

Life Esidimeni inquest postponed until August 30

The lawyer for the bereaved families argued that Dr Makgabo Manamela’s requests for postponements have a negative impact on the families of the deceased who seek closure

RECAP: Mbeki tells ANC that land without compensation goes against...

‘This would be a very serious disincentive to investment,’ says Thabo Mbeki in a document arguing that the ANC should not proceed with the Constitutional amendment of section 25

More top stories

How to apply for the Covid-19 R350 grant

Asylum seekers with valid permits and caregivers will now also be allowed to apply for the reinstituted social relief of distress grant

Long arm of the riots still affecting health sector

The tumult in KwaZulu-Natal and Gauteng has forced people to go without chronic medication and check-ups, caused shortages at the blood bank and disruptions in the vaccine roll out

Deadly result as state forces seize ‘loot’ in Durban

In Madlala, the police and army broke into homes in an operation to retrieve stolen goods. After they left, a woman lay dead in a pool of her blood behind a shack

Getting Covid-19 after being vaccinated can happen – but it’s...

Vaccines help to reduce the spread of Covid-19, but they are not without shortcomings. Here’s what they can and can’t do

press releases

Loading latest Press Releases…